News

Deal Announcements

Immusoft Secures New Venture Debt Funds

Thursday, August 20, 2015 5:46:00 AM PDT | VentureDeal
   Seattle, Washington  --  Biotechnology company Immusoft has raised $375,000 in new venture capital debt financing, according to an SEC regulatory filing.

Immusoft has developed technology that "turns a patient's own B cells into miniature drug factories."

The technology promises to create a new platform for the delivery of medicines.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Immusoft is still seeking $625,000 in additional debt financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1